Ignite Creation Date:
2025-12-25 @ 2:50 AM
Ignite Modification Date:
2026-01-06 @ 6:44 AM
Study NCT ID:
NCT07107633
Status:
RECRUITING
Last Update Posted:
2025-08-06
First Post:
2025-07-10
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase II Clinical Study to Evaluate the Efficacy and Safety of Technetium [99mtc]-H7ND Injection in the Diagnosis of Peritoneal Metastasis of Gastrointestinal Malignant Tumor.
Sponsor:
Jiaxing Pharmadax Genesis Pharmaceutical Technology Co.,Ltd.
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
2025-024R
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None